Diprosalic Scalp Application
*Company:
Organon Pharma (Ireland) LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 26 January 2023
File name
IE-Diprosalic Scalp-EN-SPC-20210730-CRT.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 December 2022
File name
QRD-ie-Diprosalic Lotion 100mL-PIL-IAIN Heist Name Change-CRT.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 26 August 2021
File name
IE-Diprosalic Scalp-EN-SPC-20210730-CRT.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 26 August 2021
File name
QRD-ie- Diprosalic Lotion- PIL-100ml CRT_.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 27 June 2019
File name
Diprosalic SA PRAC 4.4 4.8 Sep 17.pdf
Reasons for updating
- Improved presentation of SPC
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Converted the SPC from word document to pdf file format
Updated on 25 June 2019
File name
Diprosalic SA PRAC 4.4 4.8 Sep 17.
Reasons for updating
- Improved presentation of SPC
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Converted the SPC from word format to pdf file format
Updated on 10 October 2017
File name
PIL_14527_266.pdf
Reasons for updating
- New PIL for new product
Updated on 10 October 2017
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 10 October 2017
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
SPC change details: 4.4: Visual disturbances and corticosteroid use 4.8: Blurred vision added to list of possible side effects.
Updated on 10 October 2017
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 10 February 2017
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 19 March 2015
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
- Change to Section 4.8 - Undesirable effects
Updated on 19 March 2015
Reasons for updating
- Change to side-effects
Updated on 22 April 2014
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 22 April 2014
Reasons for updating
- Change to MA holder contact details
Updated on 29 August 2012
Reasons for updating
- Change to side-effects
Updated on 07 August 2012
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 4.9 - Overdose
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 05 May 2011
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Section 6.3 - Reduction in shelf-life from 2 years to 18 months
Updated on 11 April 2011
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - MA number
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 08 April 2011
Reasons for updating
- Change to date of revision
- Change to marketing authorisation holder
Updated on 08 September 2010
Reasons for updating
- Change to storage instructions
- Change to further information section
- Change to date of revision
- Correction of spelling/typing errors
Updated on 19 January 2010
Reasons for updating
- New PIL for medicines.ie
Updated on 14 September 2009
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 6.2 - Incompatibilities
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 9 - Date of renewal of authorisation
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Section 1
From: Diprosalic Ointment
To: Diprosalic 0.05 % w/w + 3 % w/w Ointment
Section 6.2
From: None stated
To: Not applicable
Section 6.6
From: Not applicable
To: No special requirements
Section 9
Date of renewal updated to 16 March 2007
Section 10
Date of revision of text updated to November 2007
Updated on 28 May 2003
Reasons for updating
- New SPC for medicines.ie
Legal category:Product subject to medical prescription which may not be renewed (A)